TD Cowen raised the firm’s price target on McKesson (MCK) to $864 from $830 and keeps a Buy rating on the shares. The firm updated its model following its investor day where the company raised its long-term adjusted EPS guide and setting the combined long-term NA Pharma and Onc/multispecialty AOI guide higher than previous US Pharma guide.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MCK: